Emre Yekedüz

19PUBLICATIONS
66CO-AUTHORS
Haematological tumoursBasic pharmacologyMolecular targetsImmunogenetics (incl. genetic immunology)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 15, 2026
Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study.

|Apr 23, 2026
Less Can Be Enough: Optimizing Abiraterone Acetate Dosing With Food to Improve Access and Maintain Efficacy in Metastatic Castration-Resistant Prostate Cancer.

|Jan 12, 2026
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.

Emre Yekedüz, Weiwei Bian, Stephanie E Siegmund

|Jan 28, 2025
Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors.

Merih Yalçıner, Satı Coşkun Yazgan, Eda Eylemer Mocan

|Jul 17, 2024
Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors.

Beliz Bahar Karaoğlan, Emre Yekedüz, Satı Coşkun Yazgan

|Oct 19, 2022
The effect of primary tumour resection on patients with synchronous metastatic colorectal cancer treated with cetuximab-containing regimens.

Elif Sertesen, Emre Yekedüz, Elif Berna Köksoy

Pageof 4

Frequent Collaborators

13 joint publications

Yüksel Ürün

5 joint publications

Güngör Utkan

4 joint publications

Elif Berna Köksoy

3 joint publications

Satı Coşkun Yazgan